| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |